BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36484757)

  • 1. Regulatory Risk Assessment of Pharmaceuticals in the Environment: Current Practice and Future Priorities.
    Oldenkamp R; Hamers T; Wilkinson J; Slootweg J; Posthuma L
    Environ Toxicol Chem; 2024 Mar; 43(3):611-622. PubMed ID: 36484757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).
    Duarte DJ; Niebaum G; Lämmchen V; van Heijnsbergen E; Oldenkamp R; Hernández-Leal L; Schmitt H; Ragas AMJ; Klasmeier J
    Environ Toxicol Chem; 2022 Mar; 41(3):648-662. PubMed ID: 33818825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals and Personal Care Products in the Aquatic Environment: How Can Regions at Risk be Identified in the Future?
    Wilkinson JL; Thornhill I; Oldenkamp R; Gachanja A; Busquets R
    Environ Toxicol Chem; 2024 Mar; 43(3):575-588. PubMed ID: 37818878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Approaches Should be Used to Prioritize Pharmaceuticals and Personal Care Products for Research on Environmental and Human Health Exposure and Effects?
    Mo J; Guo J; Iwata H; Diamond J; Qu C; Xiong J; Han J
    Environ Toxicol Chem; 2024 Mar; 43(3):488-501. PubMed ID: 36377688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers.
    Bouzas-Monroy A; Wilkinson JL; Melling M; Boxall ABA
    Environ Toxicol Chem; 2022 Aug; 41(8):2008-2020. PubMed ID: 35730333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecological risk assessment of fifty pharmaceuticals and personal care products (PPCPs) in Chinese surface waters: A proposed multiple-level system.
    Liu N; Jin X; Feng C; Wang Z; Wu F; Johnson AC; Xiao H; Hollert H; Giesy JP
    Environ Int; 2020 Mar; 136():105454. PubMed ID: 32032889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals and personal care products (PPCPs) in Arctic environments: indicator contaminants for assessing local and remote anthropogenic sources in a pristine ecosystem in change.
    Kallenborn R; Brorström-Lundén E; Reiersen LO; Wilson S
    Environ Sci Pollut Res Int; 2018 Nov; 25(33):33001-33013. PubMed ID: 28762048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceuticals and personal care products in the aquatic environment in China: a review.
    Bu Q; Wang B; Huang J; Deng S; Yu G
    J Hazard Mater; 2013 Nov; 262():189-211. PubMed ID: 24036145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International scientists' priorities for research on pharmaceutical and personal care products in the environment.
    Rudd MA; Ankley GT; Boxall AB; Brooks BW
    Integr Environ Assess Manag; 2014 Oct; 10(4):576-87. PubMed ID: 24954797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental Risks of Pharmaceutical Mixtures in Aquatic Ecosystems: Reflections on a Decade of Research.
    Kidd KA; Backhaus T; Brodin T; Inostroza PA; McCallum ES
    Environ Toxicol Chem; 2024 Mar; 43(3):549-558. PubMed ID: 37530415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
    Aubakirova B; Beisenova R; Boxall AB
    Integr Environ Assess Manag; 2017 Sep; 13(5):832-839. PubMed ID: 28120523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Environmental Exposure to Pharmaceutical and Personal Care Product Residues Result in the Selection of Antimicrobial-Resistant Microorganisms, and is this Important in Terms of Human Health Outcomes?
    Stanton IC; Tipper HJ; Chau K; Klümper U; Subirats J; Murray AK
    Environ Toxicol Chem; 2024 Mar; 43(3):623-636. PubMed ID: 36416260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first screening and risk assessment of pharmaceuticals and additives in personal care products in waste water, sludge, recipient water and sediment from Faroe Islands, Iceland and Greenland.
    Huber S; Remberger M; Kaj L; Schlabach M; Jörundsdóttir HÓ; Vester J; Arnórsson M; Mortensen I; Schwartson R; Dam M
    Sci Total Environ; 2016 Aug; 562():13-25. PubMed ID: 27092417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and ecological risks of pharmaceuticals in a Mediterranean river in Eastern Spain.
    Fonseca E; Hernández F; Ibáñez M; Rico A; Pitarch E; Bijlsma L
    Environ Int; 2020 Nov; 144():106004. PubMed ID: 32745782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advances on the pollution of pharmaceutical and personal care products (PPCPs) in natural waters and their toxicity to freshwater algae.].
    Ding TD; Li W; Kan XL; Li JY
    Ying Yong Sheng Tai Xue Bao; 2019 Sep; 30(9):3252-3264. PubMed ID: 31529901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence, removal and environmental risk assessment of pharmaceuticals and personal care products in rural wastewater treatment wetlands.
    Chen Y; Vymazal J; Březinová T; Koželuh M; Kule L; Huang J; Chen Z
    Sci Total Environ; 2016 Oct; 566-567():1660-1669. PubMed ID: 27342641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of distribution and risk of pharmaceuticals and personal care products in the aquatic environment in China.
    Xiang Y; Wu H; Li L; Ren M; Qie H; Lin A
    Ecotoxicol Environ Saf; 2021 Apr; 213():112044. PubMed ID: 33601171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
    Kosma CI; Lambropoulou DA; Albanis TA
    Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritisation of data-poor pharmaceuticals for empirical testing and environmental risk assessment.
    Cannata C; Backhaus T; Bramke I; Caraman M; Lombardo A; Whomsley R; Moermond CTA; Ragas AMJ
    Environ Int; 2024 Jan; 183():108379. PubMed ID: 38154319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.